Discordant [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT Uptake in Three Synchronous Malignancies: A Case Report
A 68-year-old woman underwent [18F]fluorodeoxyglucose (FDG) and [68Ga]Ga-fibroblast activation protein inhibitor (FAPI)-46 positron emission tomography/computed tomography (PET/CT) for suspected lung cancer. FDG showed high uptake in bilateral lung lesions, whereas FAPI exhibited high uptake in the left lesion but minimal uptake in the right lesion. FAPI additionally revealed an FDG-negative incidental oropharyngeal focus. Histopathological evaluation confirmed two synchronous primary lung adenocarcinomas with different histological profiles, and biopsy of the tongue base revealed a squamous cell carcinoma arising from a minor salivary gland. In conclusion, this patient presented with three synchronous cancers with different uptake patterns on FDG and FAPI PET/CT, supporting the complementary diagnostic role of both tracers.
Authors
- Morten Bentestuen (ORCID: https://orcid.org/0000-0001-6115-0967)
- Emilia Fortunati (ORCID: https://orcid.org/0000-0001-5454-9603)
- Anne Hauge Thostrup (ORCID: https://orcid.org/0009-0001-2397-0961)
- Giulia Cuzzani (ORCID: https://orcid.org/0000-0001-8381-0268)
- Andrea Farolfi (ORCID: https://orcid.org/0000-0002-5443-4301)
Institutions
- Aalborg University Hospital (DK)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Aalborg University (DK)
- University of Bologna (IT)
Publication Details
- Journal
- World Journal of Nuclear Medicine
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1055/s-0046-1830023
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00